market research on insulin

A MARKET RESEARCH ON INSULIN BRAND

Submitted to, Mr. Kaship Pandey

Submitted by, Ashish KumarKeshri Roll no. PGD-08017

1

EXECUTIVE SUMMARY
The growth rate is Pharma companies in India is very high. In the year 2008, Indian pharmaceutical market was assessed at $7,743m which witnessed an augmentation of 4.0% over 2007. Business observers predict that the Indian pharmaceutical market will escalate at an increasing mode as compared to the global pharmaceutical market, at a CAGR of 13.2% during the fiscal years 2009-14 to reach an overall worth of $15,490m in 2014.

India has also appeared as the preferred location for the pharmaceutical companies of the world because of its towering growth scenario furnished by elderly population, alteration in disease profile, developing patent system and socio-economic circumstances.

The competition in the Indian pharmaceutical market is cutthroat and the market is divided among the top 10 pharma companies accounting for 36.1% of the overall R&H sales in the fiscal year2008.

The increasing number of diabetes patients globally is proving a boon for diabetes drugs market. The number of diabetic patients in the world is estimated to reach at more than 250 Million in 2008. The governments worldwide are taking initiatives on various research and development projects in order to improve drug delivery techniques. This may be beneficial in terms of growing consumer base in developing countries like India and China This research is about growth of insulin in south delhi and north delhi(Pitampura).the main objective of this research is to find out different insulin brand available in the market ,to find out the market share of different insulin producing companies, and to find out the doctors who are prescribing these insulins. For this the primary data is collected by different chemist store from south and north delhi.to know that how much insulin that particular chemist store sells from their counter and also know that the number of quantity of all insulin brand that he sell from there store. And then according to that data I have calculated the market share of all the companies.
2

ACKNOWLEDGEMENT

Some Says ³Managers are born and some says managers are made´. I was also in some dilemma before commencing my project. But after the successful completion of my project I came to know that managers are made if they are guided properly and are motivated to work willingly towards fulfillment of specific goal.

It is with a sage sense of gratitude, I acknowledge the efforts of whole hosts of well - wishers who have in some way or other contributed in their own special ways to the success and completion of this project

This project of INSULIN is based on market survey of various chemist store and current market scenario. I would like to thank Mr. Kaship Pandey, who provides me the direction to prepare this project. I am able to prepare this project only with because of the guideline of Mr.Pandey. He guide me for procedure of market research, talk with the chemist store owner and how to face the difficulties of market.

I will be highly obliged to him for this and for helping me to complete my Market research successfully.

Ashish Kumar Keshri

3

CERTIFICATE

This is to certify that Mr. ASHISH KUMAR KESHRI, Roll Number PGD08017 of PGDM fifth term is a bonafide regular student of this institute for the session 20082010. He has completed the market research report titled ³Market Research on Insulin Brand´ under my supervision, as a part of partial fulfillment for the award of PGDM degree under AICTE. His report is satisfactory and not copied from anywhere to the best of my knowledge.

DATE: Signature: Project supervisor (Mr. Kaship Pandey)

Signature: (Head of the Department)

4

Table of Content Page No. y Objective« «««««««««««««««««««« 6 y Pharmaceutical Industry ««««««««««««... 7 y Insulin«««««.««««««««««««««... 8-10 y Profile of companies that are market leader of Insulin«11-14 y Research Methodology«««««««««««««.15-17 y Primary data of Pitampura..«««««««««««..18-23 y Primary data of South Delhi«««««««««««.23-38 y 4 P¶s of Marketing«««««««««««««««39-46 y Data Interpretation«««««««««««««........47-50 y Findings«««««««««««««««««««.50 y Bibliography«««««««««««««««««..51

5

Objective:
The main objective of this project is:
 To find out different brands of insulin available in the market  To find out company that are producing these brand  To find out doctors who are prescribing these brands and how many prescription per week.  To know the average sale of these brands per week from your counter

6

Brief Introduction About Pharmaceutical Industry in India

India's emerging pharmaceutical industry has appeared as the world leader in the fabrication of standard generic drugs, ever since the Patent Act 1970 permitted India to seriously approach and contribute in the pharmaceutical market worldwide. India is the preferred nation for pharmaceutical generation, with low charges for research and development as well as production of drugs. And the pharmaceutical companies in India have made full use of the favorable environment offered by the country to make it big. The workforce and technological proficiency of pharmaceutical companies in India ensures the growth of the industry on a global scale as well as within India. The sector is predicted to value about $3.1 billion (USD).

Growth of Indian Pharmaceutical market

In the year 2008, Indian pharmaceutical market was assessed at $7,743m which witnessed an augmentation of 4.0% over 2007. Business observers predict that the Indian pharmaceutical market will escalate at an increasing mode as compared to the global pharmaceutical market, at a CAGR of 13.2% during the fiscal years 2009-14 to reach an overall worth of $15,490m in 2014. India has also appeared as the preferred location for the pharmaceutical companies of the world because of its towering growth scenario furnished by elderly population, alteration in disease profile, developing patent system and socio-economic circumstances. The competition in the Indian pharmaceutical market is cutthroat and the market is divided among the top 10 pharma companies accounting for 36.1% of the overall R&H sales in the fiscal year 2008.

India began to abide by the World Trade Organization's Trade Related Aspects of Intellectual Property Rights (WTO-TRIPS) agreement and acknowledged product rights after the revision of the Indian Patent Act in January 2005. Indian firms are laying out strategies to benefit from the Japanese government proposal to endorse generic drugs to minimize healthcare charges.

7

INSULIN
The increasing number of diabetes patients globally is proving a boon for diabetes drugs market. The number of diabetic patients in the world is estimated to reach at more than 250 Million in 2008. The governments worldwide are taking initiatives on various research and development projects in order to improve drug delivery techniques. This may be beneficial in terms of growing consumer base in developing countries like India and China. The main requirement of present market is to develop efficient delivery methods at low cost and this may change the scenario of the industry. In the human insulin space there are as many as seven brands of both Indian companies and multinationals. The brands available in the country include Insugen of Biocon (2004), Huminsulin of Eli Lilly and Company India (1995), Wosulin of Wockhardt (2003), Recosulin of Shreya Life Sciences (2004), Human Mixtard of Novo Nordisk, Insuman of Aventis Pasteur, Human Mixact of USV, Mixulin of Cadila Pharmaceuticals. Most of these brands are available in vial form with different strengths ranging from 40 iu/ml-100 iu/ml. During 2003±2004 alone, as many as three companies launched human insulin products under different brands averaging at $3 per 10 ml vial. The human insulin market is growing at the rate of 40.5 percent in the insulin market. Wockhardt was the first Indian company to launch the country¶s indigenously developed recombinant human insulin under the brand Wosulin at $3 per 10 ml vial in September 2003. With this it became the first Indian company to launch recombinant human insulin in Asia. Even US Vitamins launched its human insulin product in 2001 but its focus remained on animal insulin. The market for animal insulin products is coming down with increase in human insulin. A year later Bangalore-based Biocon Ltd announced the launch of Insugen, the new generation bio-insulin in November 2004. Insugen was made available to the public in 10 ml vials of 40 iu/ml for an introductory price of $2.8. Shreya Life Sciences, the Indian arm of Moscow-based Shreya Corporation too launched human insulin under the brand name Recosulin in December 2004, exactly a month after the launch of Insugen. Shreya has launched Recosulin at $3 per 10 ml vials (rate fixed by National Pharmaceutical Pricing Authority (NPPA) by importing the finished product from Bioton, Poland (manufactured using BTGC technology). Besides Indian companies Eli Lilly entered the Indian insulin market a decade ago (in 1995) under the brand Huminsulin. Before that Novo Nordisk launched its human insulin product and went on to introduce insulin analogs under the brand NovoMix 30 (Premixed Insulin Analogue) and NovoRapid (Rapid Acting Insulin Analogue) for the first time in India. In August 2005, Eli Lilly & Co. India too launched its insulin analogs under the brand Humalog Mix 25-50. Although there are many brands in this space from both local and multinational companies, Rajesh Nanavati, marketing controller, Biogen and Biolife, Shreya Life Sciences observed, ³I don¶t see any competition in the market. We want to focus on our USPs to enhance credibility for our products among patients and doctors and look for growth. Our focus is to provide better and quality product to the customers. It will help us to reach our target of $2.2 million in one year.´
8

Novo Nordisk leads the domestic market as its sales during last year stood at $24 million, followed by Eli Lilly at $1.2 million and Wockhardt with about $2 million. However, the Indian companies have to put in efforts to capture the market amid stiff competition from the established multinational companies such as Novo Nordisk, Eli Lilly and Aventis Pasteur. This is mainly because diabetes patients have been using brands of multinationals for many years.

Definition: One of many hormones that help the body turn the food we eat into energy and
helps store energy to be used later. People with diabetes mellitus, a condition in which the body does not make enough insulin, might need to inject themselves with insulin to help their bodies' cells work properly or Insulin is a hormone that helps move glucose from out of our blood and into our cells so that we can use the glucose for energy. The glucose comes from most of the food that we eat. Insulin lower blood glucose levels facilitates glucose transport in cells and glucose utilization. Increase lipid and glycogen synthesis. Insulin increases amino acid transport into cells and prevents release of amino acids from muscle. Increases movement of K+ and mg2+ into cells. Insulin preparations irrespective of their onset and duration of action into rapid, intermediate or long acting. There are three characteristics that define types of insulin.
y y y

Onset: How long it takes for the insulin to start lowering blood glucose. Peak Time: Time after injection when the insulin is the most effective at lowering blood glucose. Duration: How long the insulin keeps lowering blood glucose

Insulin is prescribed by matching the characteristics of a particular insulin with the individual needs of the patient. Some people are on only one kind of insulin, while others take a combination of insulin medication to customize good glucose control. There are four main types of insulin available.
y y y y

Rapid acting Regular Intermediate acting Long acting

All Insulin are not created equal, each kind has its own unique action. They are not interchangeable. Each type of insulin has a specific job to do. Insulin is injected into the fast tissue which helps it absorb into the blood stream. Some insulin medications work faster than others but doesn¶t last as long, and some insulins last longer but work more gradually than others.

9

Diabetes
Diabetes is a condition in which a person has a high blood sugar (glucose) level as a result of the body either not producing enough insulin, or because body cells do not properly respond to the insulin that is produced. There are mainly two types of Diabetes: With type 1 diabetes, most of the insulin-producing cells in the body (the pancreatic beta cells) have been destroyed. This limits the amount of insulin available to use or store glucose from food. so the glucose keeps circulating in the blood with no way out. As a result, all individuals with type 1 diabetes need to take supplemental insulin to control their blood glucose levels. With type 2 diabetes, the pancreas may still produce insulin, but several situations can occur. The pancreas produces insufficient amounts, or the body resists the insulin or doesn¶t make optimal use of it.

10

Profile of companies that are market leader of Insulin

Eli Lilly and Company
Eli Lilly was founded by pharmaceutical chemist, Eli Lilly, on 10th May 1876. Its global headquarters are at Indianapolis, Indiana (USA). Eli Lily and Company (India) Pvt. Ltd. is a subsidiary of the US pharmaceutical company, Eli Lilly and Company. It was established in 1993 as Eli Lilly Ranbaxy Ltd, a 50:50 joint venture between Eli Lilly and Ranbaxy Laboratories Ltd. With the acquisition of 50% stake from Ranbaxy in 2001, Eli Lilly and Company created its Indian subsidiary as Eli Lilly and Company (India) Ltd. In India.

Some facts about Eli Lilly
Lilly India has made it to the Top 10 list of ³Best Companies to Work for, in India" in Business Today-Mercer-TNS survey 2008. With an annual turnover of more than US$ 18.63 Billion, Eli Lilly & Co. features in the list of Fortune-500 companies. A heritage more than 133 years strong: company founded on May 10, 1876 Approximately 40,217 employees worldwide

Lilly has research and development facilities in more than 8 countries and conducts clinical trials in more than 50 countries. A leader in the pharmaceutical industry in RD investment as a percentage of sales: 18.7 % Products marketed in 143 countries Lilly India's Performance Management process was identified as one of the Top 10 in HR Best Practices Survey conducted by Watson & Wyatt.

11

Products of Eli Lilly
Diabetes
Exenatide Human Insulin ( r- DNA) Insulin Analog ( r- DNA) Insulin Delivery Device

Severe Sepsis
Drotrecogin-alfa (activated)

Cardiology
Abciximab

Growth Hormone
Somatropin

Oncology
Gemcitabine Pemetrexed Disodium

Severe Osteoporosis
Teriparatide

12

Novo Nordisk
Novo Nordisk is synonymous with diabetes care inIndia . Novo Nordisk has introduced products and services hitherto not seen in the area of diabetes care in the country. Over the last decade Novo Nordisk has been able to ensure that there is a marked improvement in the way people with diabetes live and work. As part of our efforts to be at the forefront of bringing information to people with diabetes in India, we have attempted to highlight various aspects of diabetes which you would like to know about. As part of our activities, we have always endeavoured to stay in touch with persons with diabetes as well as the medical fraternity.

History of NN India

Novo Nordisk India story

The genesis of Novo Nordisk India goes back to 1990 when a liaison office of Novo Nordisk A/S, was set up in Mumbai. Prior to this Novo Nordisk A/S products were marketed in India through various other companies. Even then, Novo Nordisk was involved in creating awareness in diabetes care with the help of healthcare professionals in India.

On April 1, 1994, Novo Nordisk (I) Pvt. Ltd. was set up with its headquarters in Bangalore with 26 employees. It has now been rechristened as Novo Nordisk India Private Limited.

In 1998, recognising the intense need to provide awareness and education in healthcare in India, the Novo Nordisk Education Foundation (NNEF) was founded. NNEF is a non-profit organisation, with a mission of "Enhancing healthcare through awareness and education".

Novo Nordisk India's portfolio of products and services deals with therapy areas in Diabetes, Human Growth Hormone and Haemostasis Management. Novo Nordisk uses recombinant DNA technology to make innovative products for people with diabetes. We first marketed insulin for commercial use in 1923, and today we offer a comprehensive line of human insulin and insulin analog products.
13

Novo Nordisk offers three different types of insulin designed to meet the needs of people with diabetes:
y y y

Long-acting: Levemir® insulin is a long-acting insulin that provides up to 24 hours of blood sugar control. Click here for Prescribing Information Rapid-acting: NovoLog® is a rapid-acting insulin that can be taken 5 to 10 minutes before a meal. Click here for Prescribing Information Dual-acting: NovoLog® Mix 70/30 is a single insulin that provides coverage at mealtime and in between meals. Click here for Prescribing Information

ABBOTT
Abbott distributes pharmaceutical, nutritional, diagnostic and medical products in more than 130 countries worldwide. More than 120 years ago, 30-year-old Dr. Wallace C. Abbott, a practicing physician and pharmacy proprietor, founded the company that bears his name. Using the active part of a medicinal plant, known as the "alkaloid," he formed tiny pills, called "dosimetric granules," which provided more accurate and effective dosing for his patients than other treatments available at the time. The demand for these accurate granules soon far exceeded the needs of his own practice and, from these modest origins, was born Abbott, one of the world's most broadbased health care companies and a global leader in the discovery, development and manufacture of products that span the continuum of care.

AVENTIS
Aventis Pharma Limited was incorporated in May 1956 under the name Hoechst Fedco Pharma Private Limited. Over the years, its name was changed to Hoechst Pharmaceuticals Private Limited, Hoechst India Limited and Hoechst Marion Roussel Limited. Sanofi-aventis, one of the world's leading pharmaceutical companies, and its 100% subsidiary, Hoechst GmbH, are the major shareholders of Aventis Pharma Limited and together hold 50.12% of its paid-up share capital. The shares of Aventis Pharma Limited are quoted on the Bombay Stock Exchange (Security Code: 500674) and the National Stock Exchange (Security Code: AVENTIS EQ).

14

RESEARCH METHDOLOGY

Research ± Research is common parlance refers to a search for knowledge. The Advanced Learner¶s Dictionary of Current English lays down the meaning of research as ³A careful investigation or inquiry specially through search for new facts in any branch of knowledge´ According to Redman & Mory ³A systematized effort to gain new knowledge.´

Research Methodology- It is the way to systematically solve the research problem. It may be understood as a science of studying how research is done scientifically. In it we study the various steps that are generally adopted by a researcher in studying his research problem along with the logic behind them.

Types of research Design:1. Descriptive Research Design ± Descriptive research studies are those studies which are concerned with describing the characteristics of a particular individual, or of a group. 2. Hypothesis Research Design ± Hypothesis testing research studies (generally known as experimental studies) are those where researcher tests the hypotheses of causal relationship between variables. 3. Exploratory Research Design - Exploratory research studies are also termed as formulative Research studies. The main purpose of such studies is that of formulating a problem for more precise investigation or of developing the working hypothesis from and operational point of view. The major emphasis in such studies is on the discovery of idea and insights. As such the research design appropriate for such studies must be flexible enough to provide opportunity for considering different aspects of problem under studies.

15

Sampling- Sampling may be defined as the selection of some part of an aggregate or totality on the basis of which a judgment about the aggregate is made. In other words, process of obtaining information about an entire population by examining only a part of it.

Types of sampling:1. Systematic Sampling- The most practical way of sampling is to select every ith item on a list. This kind of sampling known as systematic sampling. 2. Stratified Sampling- If a population from which a sample is to be drawn does not constitute a homogeneous group, stratified sampling technique is applied in order to obtain representative sample. 3. Cluster Sampling- If the total area of interest happens to be big one, a convenient way in which is sample can be taken is to be divided into smaller non-overlapping areas called cluster known as cluster sampling. 4. Non probability sampling- In case of non probability sampling it is considered appropriate to use a random selection process where the probability of each cluster being included in the sample is proportional to size of the cluster.

16

Methodology:
Primary research is conducted for finding out different types of insulin brands available in the market, their average sales per week and the doctors prescribing these brands. This data needs to be collected from South Delhi market namely Yusuf Sarai, Madangir, Malviya Nagar, Khanpur, Hauzrani and North Delhi market namely Pitampura. The respondents are chemist shops who are the primary seller¶s of this product. Various parameters used in research: Research Design ± Descriptive Data Source ± Primary Research Instrument ± Questionnaire Sample Plan ± Delhi Sample Size ± 43 Sampling Procedure ±Judgement sampling Sampling Method ± Personal survey method

17

Primary Data
Report of Pitampura
1) Feel good Chemist G-6/7, MAG Plaza, DP Block, Pitampura, Delhi-34 Hemant Kaushik - 9868828790 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Mixtrad40(Abbott) Actrapid(Novo) H.Acttrapid100(Abbott) Avg. Sale Per Week 2 2 1 1 Dr. Prescribing these Brand Dr. Brij Mohan No. of Prescription per week 4

2) Sheetal Medical Store DP Block, Infront of MAG Plaza, Pitampura, Delhi-34 Number: 27317735 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Mixtrad((Novo) Wousulin 3) Malik Medicos Shop no.-1, JP Market, Pitampura No. -27327314 Insulin Brand Available in the store H.Insulin30/70(E.lily) H.Mixtrad30(Novo) H.Mixtrad40(Abbott) H.Mixtrad50(Novo) Actrapid MC(Abbott) Avg. Sale Per Week 2 1 1 1 1 Dr. Prescribing these Brand Dr. Subodh Gupta Dr. Dinesh Mittal No. of Prescription per week 3 2 Avg. Sale Per Week 2 1 1 Dr. Prescribing these Brand Dr.Anil Singhal No. of Prescription per week 3

18

4) S.Kumar Chemico Shop no. -5, JP Market, Pitampura No. -27327314 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Insulin N( ³ ) H.Insulin R( ³ ) H.Mixtrad30(Novo) H.Mixtrad50( ³ ) H.Mixtrad40(Abbott) Wosulin(Wockhard) 5) Rashmi Medicos JP-6.Maurya Enclave, Near Gopal Mandir, Pitampura, Delhi-88 K.K.Manwani- 27323939 Insulin Brand Available in the store H.Insulin30/70(E.lilly) H.Insulin N( ³ ) H.Insulin R( ³ ) Humalog( ³ ) Novo Rapid Flexpen(Novo) H.Mmixtrad¶all¶ Novelet Pen(Novo) H.Actrapid(Abbott) Wosulin (Wockhard) Lantus(Aventis) Avg. Sale Per Week 10 2 2 2 2 15 1 1 1 1 Dr. Prescribing these Brand No. of Prescription per week Avg. Sale Per Week 3 2 2 2 2 2 1 Dr. Prescribing these Brand No. of Prescription per week

Dr.Brij Mohan

6

Rashmi Hospital Dr.Subodh Gupta Dr. Rajiv Divan

10 3 3

19

6) Global Helpline Pvt. Ltd Opp. Rashmi Hospital, JP Market, Pitampura Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Insulin N( ³ ) H.Mixtrad 30(Novo) H.Mixtrad40(Novo) Actrapid(Novo) Insugen N (Bicon) 7) Krishna Medicos AP Block DDA Market, Pitampura Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Mixtrad30(Novo) H.Acrapid(Abbott) Wosulin(Wockhard) 8) Royal Medicos Shop no. 45, DDA Market, AP Block, Pitampura Rishabh Gaurav- 9868648899 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) Humalog Mix( ³ ) H.insulin N( ³ ) H.Mixtrad¶all¶ (Novo) Lantus(Aventis) Insugen30/70(Bicon) Insugen50/50(Bicon Insugen R( ³ ) H.Monotard(Abbott) Wosulin(Wockhar) Avg. Sale Per Week 3 2 1 3 1 1 1 1 1 2 Dr. Prescribing these Brand No. of Prescription per week Avg. Sale Per Week 2 1 1 1 Dr. Prescribing these Brand Dr. K.K.Goel No. of Prescription per week 2 Avg. Sale Per Week 2 1 1 2 1 1 Dr. Prescribing these Brand No. of Prescription per week

Rashmi Hospital

5

Dr.Amit.Gautam

5

20

9) Vishakha Dharmik Medicos CD Block, Pitampura No.-69912257, 9811158908 Insulin Brand Available in the store H.Insulin¶all¶ (E.Lilly) Humalog Mix( ³ ) H.Mixtrad(Novo) Lantus(Aventis) Lantus Optisets( ³ ) Insugen(Bicon) 10) Pranam Medical DDA Market, Pitampura Insulin Brand Available in the store H.Mixtrad(Novo) H.Insulin(E.Lilly) Penfill(Novo) Wosulin(Wockhard) Lantus(Aventis) Insugen(Bicon) Avg. Sale Per Week 2 2 1 1 1 1 Dr. Prescribing these Brand No. of Prescription per week Avg. Sale Per Week 3 2 4 1 1 1 Dr. Prescribing these Brand No. of Prescription per week

Dr.Anil

4

Dr. Suraj Singhal

4

11) Healthy Medicos Shop No.-29, BD Market, Pitampura Insulin Brand Available in the store H.Mixtrad(Novo) H.Insulin30/70(E.Lilly) Humalog mix( ³ ) Actrapid (Novo) Avg. Sale Per Week 2 1 1 1 Dr. Prescribing these Brand Dr. Brij Mohan No. of Prescription per week 3

21

12) Satya Mediways Chemist Shop no.-29, DDA Market, Pitampura Anil Kumar- 9811872296 Insulin Brand Available in the store H.Mixtrad30(Novo) H.Mixtrad40(Abbott) H.Insulin30/70(E.Lilly) H.Insulin N( ³ ) Humalog Mix( ³ ) Actrapid(Novo) Penfill( ³ ) Lantus(Aventis) 13) Gokul Medicos Shop no-31, DDA Market, Pitampura Vishal-9873686436 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Insulin N( ³ ) H.Insulin R( ³ ) H.Mixtrad(Novo) Actrapid( ³ ) NovoMix( ³ ) Avg. Sale Per Week 2 1 1 1 1 1 Dr. Prescribing these Brand No. of Prescription per week Avg. Sale Per Week 2 1 2 1 1 1 1 1 Dr. Prescribing these Brand No. of Prescription per week

Dr.Satish Bijmani

5

Dr.Maheshwari

3

22

14) Guru Kirpa Medicos Shop no.-14, L.S.C., LU DDA Market, Pitampura Anil -27342925 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Mixtrad(Novo) Mixtrad Novelet( ³ ) Mixtrad 30 HM(Abbott) Lantus(Aventis) NovoMix(Novo) Avg. Sale Per Week 2 2 1 5 1 1 Dr. Prescribing these Brand No. of Prescription per week

Dr. Maheshwari

5

23

Report of South Delhi (Yusuf Sarai)
1) All India Medicos Ndmc market, Near Aiims, Yusuf Sarai, Delhi-16 Rahul Ph. - 66227646 Insulin brand available in the store H. insulin 30/70(E. Lilly) H. insulin N( ³ ) H. insulin R( ³ ) Humalog mix( ³ ) Novomix (Novo) Actrapid ( ³ ) H.Actrapid 100 (Abbott) H.Insulatard( ³ ) H.Insulatard(Novo) H.Mixtrad µAll¶( ³ ) H.Monotard 40(Abbott) Insugen -30/70(Biocon) Penfill(Novo) Wosulin(Wockhard) Lantus(Aventis) 2) Agarwal Medicos Near Aiims, Yusuf Sarai, Delhi 16 Insulin brand available in the store H.insulin µAll¶ (Eli Lily) Humalog Mix(³) H.mixtrad µAll¶(Novo) Novomix(³) Actrapid(³) H.insulatard(³) H.monotard(Abbott) Penfill(³) Insugen(Biocon) Lantus(Aventis) Average sale per week 10 2 12 Aiims Hospital 1 1 2 2 2 3 3
24

Average sale per week 10 3 5 2 2 1 1 1 1 12 1 2 1 2 2

Dr. Prescribing these brand

No. Of prescription per week

AIIMS Hospital Safderjung Hospital

20 15

Dr. Prescribing these brand

No. Of prescription per week

15

3) Super Medical Aid F ± 3, Yusuf Sarai Bus Stop Market, Near Aiims No ± 26588356 Insulin brand available in the store H.insulin µAll¶ (Eli Lily) Humalog Mix( ³ ) H.mixtrad µAll¶(Novo) H.insulatard ( ³ ) H M Penfill( ³ ) Isophane (Abbott) H.monotard 40( ³ ) Actraphane H M Penfill(³ ) Lantus Optisets (Aventis) Insugen µAll¶(Biocon) 4) Pioneer Medicos Shop No. ± 37, Main Market, Yusuf Sarai, Delhi -16 Insulin brand available in the store H.insulin µAll¶(Eli Lily) Humalog( ³ ) Novo Rapid Flexpen(Novo) H.Mixtrad µAll¶( ³ ) Novomix 30( ³ ) Actrapid(Abbott) H.Insulatrad( ³ ) Insugen(Biocon) Average sale per week 12 3 2 11 5 2 4 5 Dr. Prescribing these brand No. Of prescription per week Average sale per week 9 2 12 1 2 1 2 2 4 4 Dr. Prescribing these brand No. Of prescription per week

Aiims Hospital

17

Safderjung Hospital Aiims Hospital

12 10

25

5) South Delhi Medicos Opp. Aiims, Yusuf Sarai, Delhi -16 Insulin brand available in the store H.insulin µAll¶(Eli Lilly) Humalog( ³ ) Injection H.insulin 50/50(³) Iletin( ³ ) Novomix(Novo) H.mixtrad µAll¶ ( ³ ) Insulatard( ³ ) HM Penfill( ³ ) Actrapid(Abbott) Insulatrad Novelet( ³ ) Insugen µAll¶(Biocon) Lantus(Aventis) Wosulin(Wockhard) 6) Bhutani Medicos Shop No. -23, Opp. Aiims, Yusuf Sarai, Delhi -16 No. -65672277, 65672288 Insulin brand available in the store H.insulin 30/70(Eli Lilly) H.insulin N( ³ ) H.insulin R( ³ ) Humalog Mix( ³ ) Novomix(Novo) H.Mixtrad µAll¶( ³ ) Actrapid( ³ ) H.insulatard( ³ ) Insugen µAll¶(Biocon) Wosulin(Wockhard) Lantus(Aventis) H.Monotard(Abbott) HM Penfill( ³ ) Average sale per week 10 5 2 3 4 15 3 4 2 1 1 1 2 Dr. Prescribing these brand No. Of prescription per week Average sale per week 15 3 2 2 5 15 2 2 2 3 5 3 3 Dr. Prescribing these brand No. Of prescription per week

Safderjung Hospital Aiims Hospital

20 18

Aiims Hospital Safderjung Hospital

15 12

26

7) Safderjung Medicos Shop No. -22, Opp. Aiims, Yusuf Sarai, Delhi -16 No. -26192644 Insulin brand available in the store H.insulin 30/70(Eli Lilly) H.insulin N( ³ ) H.insulin R( ³ ) Humalog Mix( ³ ) H.Mixtrad µAll¶(Novo) H.insulatard( ³ ) Actraphane ±HM Penfill(Abbott) H.Actrapid( ³ ) Insugen µAll¶(Biocon) Insuman Rapid(Aventis) Lantus( ³ ) 8) All India Chemist Shop No. -1, Near gate no. 2,Safderjung Hospital,Yusuf Sarai, Delhi -16 No. -26160796, 64695631 Insulin brand available in the store H.insulin µAll¶(EliLilly) H.Mixtrad¶All¶(Novo) Novomix -30( ³ ) H.insulatrad( ³ ) Insulatard HM Penfill( ³ ) H.Monotard 40(Abbott) Insugen µAll¶(Biocon) Lantus(Aventis) Average sale per week 7 8 2 1 1 2 3 2 Dr. Prescribing these brand No. Of prescription per week Average sale per week 5 2 2 2 8 1 2 1 4 1 2 Dr. Prescribing these brand No. Of prescription per week

Safderjung Hospital Aiims Hospital

10 15

Safderjung Hospital Aiims Hospital

6 8

27

9) Medicine Corner Shop no -2, Opp. S J Hospital,Delhi 29 No. -64695484,26183370 Insulin brand available in the store H.insulin 30/70(Eli Lilly) H.Mixtrad 30(Novo) Novomix 30( ³ ) Insugen 30/70(Biocon) Insugen 50/50( ³ ) Insulatard Novelet(Abbott) Insuman Rapid(Aventis) Lantus( ³ ) Wosulin(Wockhard) 10) Help+Care Chemist 7/1 -2,L.G.F,Yusuf Sarai,New Delhi -16 NO. -9999084244,64514466 Insulin brand available in the store H.Insulin(Eli Lilly) Humalog(³) Levi Meet(³) H.mixtrad(Novo) H.actrapid(³) Novo rapid(³) Lantus(Aventis) Average sale per week 10 3 2 10 5 5 1 Dr. Prescribing these brand Dr.JS Mathur Aiims Hospital Safderjung Hospital No. Of prescription per week 5 10 5 Average sale per week 5 6 2 2 1 1 1 2 2 Dr. Prescribing these brand No. Of prescription per week

Safderjung Hospital Aiims Hospital

5 5

28

11) Paras Chemist 10/2, Yusuf Sarai, New Delhi -16 No. -011-26193685 Insulin brand available in the store H.insulin 30/70(Eli Lilly) H.Mixtrad(Novo) H.actrapid(³) Lantus(Aventis) Insugen 30/70(Biocon) Wosulin(Wockhard) 12) Bharat Medicos. 14/4, Yusuf Sarai Market, Aurobindo Road, Delhi -16 No. -26193812,26194329 Insulin brand available in the store H.insulin¶All¶(Eli Lilly) Humalog Mix(³) H.Mixtrad 30(Novo) H.Mixtrad 50(³) H.insulatard(³) Novomix(³) H.Actrapid(Abbott) H.Monotard(³) Insugen(Biocon) Lantus(Aventis) Average sale per week 12 2 7 5 4 2 3 1 2 2 Dr. Prescribing these brand No. Of prescription per week Average sale per week 7 6 1 2 3 2 Dr. Prescribing these brand No. Of prescription per week

Dr. Jasbir Singh Aiims Hospital Safderjung Hospital

4 7 6

Aiims Hospital Safderjung Hospital

8 7

29

13) Jagdamba Chemist 17/7,Main Market, Yusuf Sari,Delhi -16 No. -26193796, 26165517 Insulin brand available in the store H.insulin 30/70(Eli Lilly) H.insulin N(³) H.insulin R(³) H.insulin 50/50(³) H.Mixtrad 30(Novo) H.Mixtrad 50(³) H.Mixtrad 40(Abbott) H.insulatard(Novo) Average sale per week 5 2 2 2 4 2 2 2 Dr. Prescribing these brand No. Of prescription per week

Aiims Hospital Safderjung Hospital

5 4

14) Super Healthline Pharmacy Main Market, Yusuf Sari, Delhi ± 16 Mr. Jitendra -9013000530 Insulin brand available in the store H.insulin 30/70(Eli Lilly) H.Actrapid(Novo) H.insulin N(Eli Lilly) H.insulin R(³) H.insulatard(Novo) H.Monotard(Abbott) Lantus(Aventis) Average sale per week 4 2 3 2 2 1 2 Dr. Prescribing these brand Dr. Ravi Bansal Aiims Hospital Safderjung Hospital No. Of prescription per week 3 4 4

30

15) Chawla Chemist 72/2,Main Market, Yusuf Sarai, Delhi -16 Inder Chawla -41019157 Insulin brand available in the store H.insulin 30/70(Eli Lilly) H.insulin 50/50(³) H.insulin N(³) H.insulin R(³) H.Mixtrad(Novo) Wosulin(Wockhard) Penfill(Novo) Insugen 30/70(Biocon) Average sale per week 7 2 2 3 6 2 1 2 Dr. Prescribing these brand No. Of prescription per week

Aiims hospital Safderjung Hospital

6 4

16) Chawla;s InderMedicos Near Yusuf Sarai Bus Stop, NDMC Market,Delhi-29 PH.- 46665307,26588738 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Insulin N( ³ ) H.Insulin R( ³ ) Humalog ( ³ ) H.Mixtrad(Novo) H.Actrapid40( ³ ) Insugen 30/70(Biocon) H.Actrapid(Abbott) Avg. Sale Per Week 5 2 2 1 6 2 3 2 Dr. Prescribng these Brand No. of Prescription per week

Aiims Hospital Safderjung Hospital

4 4

31

Report of South Delhi(Madangir)
17) Shivam Medicos Shop No.-3 Plot No.-144A, Madangir, Near L.S.C Market Delhi-62 Mr. Pradeep-9818156640 Insulin Brand Available in the store H.Insulin30/70(ELilly) H.Insulin N( ³ ) H.Insulin R( ³ ) H.Mixtrad 40(Novo) H.Mixtrad50( ³ ) Wosulin(wockhard) Lantus(Aventis) Avg. Sale Per Week 2 1 1 2 1 1 1 Dr. Prescribing these Brand No. of Prescription per week

Dr. Malik Dr.Manish Mohit

2 3

18) Ten Eleven Pharmacy Shop no.-8, Gali no.-3, DDA Market, Madangir Delhi-62, Ph.-41796713 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) hHMixtrad30(Novo) H.Mixtrad40(Abbott) H.Mixtrad50(Novo) Wosulin(Wockhard) NovoMix30(Novo) H.Actrapid100(Abbott) H.Insulatard( ³ ) H.Monotard40( ³ ) Insugen¶all¶(Biocon) Avg. Sale Per Week 2 2 1 1 1 1 1 1 1 2 Dr. Prescribing these Brand No. of Prescription per week

Dr.S.K.Chaudhary Dr.Pradeep Kharbanda

2 2

32

19) Narula Pharmacy Shop no.-7, DDA Market, Phase-1, Madangir Delhi-62, ph.-29964825 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Insulin N( ³ ) H.Insulin R( ³ ) Humalog( ³ ) Insugen30/70(Biocon) Insugen N( ³ ) InsugenR( ³ ) Insugen50/50( ³ ) Actrapid(Novo) H.Insulatard( ³ ) H.Mixtrad30( ³ ) H.Mixtrad50( ³ ) Insulatrad HM Penfill(³) Acrapid Novelet(Abbott) H.Actrapid100( ³ ) H.Insulatard( ³ ) H.monotard40( ³ ) H.Actrapid40( ³ ) Lantus(Aventis) Mixtard30(Abbott) Avg. Sale Per Week 2 1 1 1 1 1 1 1 1 1 2 1 1 1 1 1 2 1 1 1 Dr. Prescribing these Brand No. of Prescription per week

Dr. Ashokanand Dr. Banajy

5 4

33

20) Mahajan Medicare Shop no.-1, DDA Shoping Centre, Madangir, Delhi-62 BB.Mahajan - 9868221440 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Insulin N( ³ ) H.InsulinR( ³ ) Humalog Mix( ³ ) Iletin( ³ ) Novoix30( ³ ) Insulatard HM Penfil( ³ ) Actrapid( ³ ) H.Mixtard30( ³ ) H.Mixtrad50( ³ ) Actrapid Novolet(Abbott) H.Actrapid100( ³ ) H.Insulatard( ³ ) H.Mixtrad40( ³ ) Insulatard Novelet( ³ ) Insugen¶all¶(Biocon) Lantus(Aventis) Lantus Optisets( ³ ) Wosulin(Wockhard) 21) Ved Medicos 5/81, Dr. Ambedkar Nagar, Sec.-11, Delhi-62, Rajeev Paswan- 9868041345 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Insulin N( ³ ) H.Insulin R( ³ ) H.Mixtrad(Novo) Insugen30/70(Biocon) Actrapid(Novo) H.Insulatard(Abbott) Mixtard30(Abbott) Lantus(Aventis) Avg. Sale Per Week 3 2 1 5 2 1 2 1 2 Dr. Prescribing these Brand No. of Prescription per week Avg. Sale Per Week 3 2 2 1 1 2 1 1 3 2 1 2 1 1 1 2 1 1 2 Dr. Prescribing these Brand No. of Prescription per week

Dr.Ashokanand Batra Hospital

5 5

Dr. Malik Batra Hospital

4 5

34

22) Akash Medical BH74 Madanigr, delhi-62 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Mixtrad30(Novo) H.Mixtrad( ³ ) Insugen N(Biocon) Insugen R(Biocon) Avg. Sale Per Week 2 1 2 2 1 Dr. Prescribing these Brand Dr.Jalaj Ranjan Batra Hospital No. of Prescription per week 3 2

Devli Khanpur

23) Kaileshwari Chemist C- 1535, Dr. Ambedkar Nagar, Sec.-1 Tigri Ph. ± 29969841 Insulin Brand Available in the store H.Insulin 30/70(E.Lilly) H.Insulin N( ³ ) H.Mixtrad40(Abbott) Actrapid Novolet( ³ ) H.Mixtrad50(Novo) Actrapid( ³ ) H.Mixtrad30( ³ ) Avg. Sale Per Week 2 1 2 1 1 1 2 Dr. Prescribing these Brand No. of Prescription per week

Batra Hospital

5

35

24) Batra Chemist 34/7 Devli Road, Khanpur, Delhi-62 Ph. ± 51653658 Insulin Brand Available in the store H.Insulin N(E.Lilly) H.Insulin R( ³ ) NovoMix30(Novo) H.Insulatard( ³ ) H.Mixtrad30( ³ ) H.Mixtrad50( ³ ) H.Mixtrad40(Abbott) Avg. Sale Per Week 3 2 1 1 2 1 2 Dr. Prescribing these Brand No. of Prescription per week

Batra Hospital

4

25) South Delhi Medical Agencies 34/14, Devli Road, Khanpur, New Delhi-62 Ashok Arora- 9810219927 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Insulin R( ³ ) Insugen30/70(Biocon) Actrapid(Novo) H.Insulatrad30( ³ ) H.Mixtrad50( ³ ) Acrapid Novelet(Abbott) H.Insulatard( ³ ) H.Actrapid40( ³ ) H.Mixtrad40( ³ ) Avg. Sale Per Week 2 2 2 1 1 2 1 1 1 2 Dr. Prescribing these Brand No. of Prescription per week

Dr Anil Vig

5

36

26) New Delhi Medicos Soptical D- 135, Krishna Park, Khanpur, Delhi- 62 Ph. ± 65699870 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Insulin R( ³ ) H.Mixtrad30 ( ³ ) Insugen(Biocon) 27) Sanjivani Devli Road, Khanpur, Delhi- 62 Insulin Brand Available in the store H.InsulinN(E.Lilly) H.InsulinR( ³ ) H.Mixtrad(Novo) Lantus(Aventis) Avg. Sale Per Week Dr. Prescribing these Brand No. of Prescription per week Avg. Sale Per Week 2 1 3 2 Dr. Prescribing these Brand Dr.Hari Om Ahuja No. of Prescription per week 5

2 2 2 1

Dr. Rajiv Dhingra

4

Hauzrani (Malvia Nagar)

28) Delhi Chemist 154- Hauz Rani, opp max Hospitals Mob. ± 9990105259 Insulin Brand Available in the store H.Insulin30/70(E.Lilly) H.Insulin R(E.Lilly) H.Mixtrad40(Abbott) H.Mixtrad50(Novo) Mixtrad30(Abbott) Avg. Sale Per Week 3 1 2 2 1 Dr. Prescribing these Brand Batra Hospital No. of Prescription per week 3

37

29) Mac Pharmacy 153 Hauzrani, Malviya Nagar, Delhi-17 Mob. ± 9910465838 Insulin Brand Available in the store Humalog Mix(E.Lilly) H.Insulin30/70( ³ ) H.Insulin N( ³ ) H.Insulin R( ³ ) Iletin( ³ ) NovoMix30(Novo) Actrapid( ³ ) H.Insulatard( ³ ) H.Mixtrad30( ³ ) H.Mixtrad50( ³ ) Actrapid(Abbott) ActrapidMC( ³ ) Actrapid Novelet( ³ ) H.Actrapid100( ³ ) H.Insulatard( ³ ) H.Mixtrad40( ³ ) H.Monotard40( ³ ) Insugen30/70(Biocon) Insugen50/50( ³ ) Insugen R( ³ ) Lantus Optisets(Aventis) Insuman Rapid(Aventis) Lantus( ³ ) Avg. Sale Per Week 1 2 2 2 1 1 1 1 3 2 1 1 1 1 1 2 1 2 1 1 1 1 2 Dr. Prescribing these Brand No. of Prescription per week

Dr. Ravi Shah Batra Hospital

4 5

38

CONCEPT OF MARKETING MIX

It is the set of marketing tools that the firm uses to pursue its marketing objectives in the target market.

4 P¶s OF MARKETING IN INSULIN BRAND

This is a major concept in traditional marketing. It consists of Product, Price, Place and Promotion. This is known as 4 P¶s of marketing mix. Companies that produce insulin brand also follows the rules of 4 P¶s of marketing. It represents the seller¶s views of marketing tools available for influencing the buyers to opt for their products.

39

4 P¶s of marketing are shown in the following diagram:

MARKETING MIX.

PRODUCT

PRICE

PLACE

PROMOTION

Not all marketing-mix variables can be adjusted in the short run. Typically, the firm can changes its price, sales force size, and advertising expenditures in the short run. It can develop new products and modify its distribution channels only in the long run. Thus the firm typically makes fewer period-to-period marketing-mix changes in the short run than the number of marketingmix variables might suggest. Finally, the marketers must decide on the allocation of the marketing budget to the various products, channels, promotion media, and sales areas.

40

PRODUCT

WHO SHOULD ULTIMATELY DESIGN THE PRODUCT?????????? THE COUSTOMER OF COURSE.

The most basic marketing-mix tool is product ± the firm¶s tangible offer to the market, which includes the product quality, design, features, branding, and packaging. Product can be defined as follows:

A PRODUCT is anything that can be offered to a market to satisfy a want or need. Products that are marketed include physical goods (automobiles, books), services (haircuts, concerts), persons (celebrities and film stars), places (Hawaii), organization and ideas (family planning, safe driving).

Here the product is INSULIN.

A) Core benefit-

It is the fundamental service or benefit that the customer is really buying. The customer purchase insulin because their body cells cannot able to produce insulin due to that glucose level increases in the blood. So it become necessary to take the insulin from outside to survive.

41

B) Basic ProductThe second level the marketers turn the core benefit into a basic generic product. You need basic infrastructure to satisfy your particular need. The basic thing that customer wants from insulin is ³convert the food that we eat into energy and also store it for later use.

C) Expected ProductAt the third level the basic product is turned into expected product, a set of attributes and conditions that buyers normally expect and agree to when they purchase this product. Buyer expected that the insulin that they take for diabeties must proof effective and control this disorder.

D) Augmented ProductAt the fourth level the marketers prepare an augmented product that meets the customer¶s desire beyond their expectations. Different companies produce different types of insulin their effects are also different in the body some start to work instantly but their rffect is for shorter time and some start working late but their effect remain for long time.

E) Potential Product-

y

Potential product is that product which company wants to provide their customers in future. We the companies like Eli Lilly planning to provide their customer in future the following features«.

y

Insulin their effect remain for long time and that start working instantly after injected this in body.

y

Improveing insulin delivry system be also Direct home delivery as and when customer required.

42

CORE BENEFIT

BASIC PRODUCT

EXPECTED PRODUCT

AUGUNANT PRODUCT

POTENTIAL PRODUCT

43

PRICE

THE BEST WAY TO ATTRACT AND KEEP CUSTOMERS IS TO CONSTANTELY FIGURE OUT HOW TO GIVE THEM MORE FOR LESS.

A Critical marketing-mix tool is price, the amount of money that customer pay for the product. More innovative ideas and features were provided by Eli Lilly and Novo Nordisk for inulin their inlulin delivery system is better in comparision of other and also their product product satisfy the customer in a better way which attracts customer and make a different mind-set for them.

Price is the only element in the marketing mix that produces revenue; the other element produce costs. Price is also one of the most flexible elements of the marketing mix, in that it can be changed quickly, unlike product features and channel commitments. At the same time, pricing and price competition are the number one problems facing many marketing executives. Yet, many companies do not handle pricing well. The most common mistake is these: Pricing is too cost oriented; price is not revised often enough to capitalize on market changes; price is set independent of the rest of the marketing mix.

Companies handle pricing in a variety of ways. In small companies, Prices are often set by top management rather by marketing or sales people. In large companies, pricing is typically handled by division and product-line managers. Even here, top management sets the general pricing objectives and policies and often approves the prices proposed by lower levels of
44

management. In industries where pricing is a key factor (aerospace, railroads, oil companies), Companies will often establish a pricing department to set prices of assist others in determining appropriate prices.

This department reports to the marketing department, the finance department, or top management. Others who exert an influence on pricing include sales managers, production managers, finance managers, and accountants.

PLACE

THE MOST IMPORTANT THING IS TO FORECAST WHERE CUSTOMERS ARE MOVING, AND TO BE IN FRONT OF THEM

Place, another key marketing- mix tool, includes the various activities they company undertakes to make the product accessible and available to target customers. One must identify, recruit, and link various marketing facilitators to supply its products and services efficiently to the target market. A businessman must understand the various types of retailers, wholesalers, and physical distribution firms and how they make their decision. Insulin brands are easily available anywhere across the country. But the companies approach in that place where the diabeties patients are high. Rural market is still not very explored in terms of insulin. But with the time the companies also approach rural market they are trying to find out the dealer and distributer for that area also which is tsill untouched.

45

PROMOTION
³SELL VALUE NOT PRICE´

Promotion, the fourth marketing- mix tool, includes all the activities the company undertakes to communicate and promote its product to the target market. In today world where everyone ready to cut the throat of everyone else, it is important to prepare from the starting because TODAY YOU HAVE RUN FASTER TO STAY IN THE SAME PLACE. Modern marketing calls for more than a developing a good product, pricing it attractively, and making it accessible to target customers. Companies must also communicate with their present and potential customers, retailers, suppliers, other stakeholders, and the general public. The marketing communications mix consists of five major modes of communication: advertising, sales promotion, public relations and publicity personal selling, and direct marketing. Lots of steps have taken for the promotion of the insulin producing companies. Its price is now reduced to make it available for all customers. To attract chemist store owners several types of gifts have given to the owner to promote these brands in the market. Advertisment through several channel is also one of the way of promotion.

46

Data Interpretation of Pitampura
Insulin Brand
HUMINSULIN 30/70 HUMINSULIN µN¶ HUMINSULIN µR¶ HUMALOG HUMALOG MIX 50 NOVO MIX ACTRAPID HUMAN MIXTRAD 30 HUMAN MIXTRAD 50 INSULATARD HM PENFIL NOVA RAPID FLEXPEN NOVOLET PEN ACTRAPID MC ACTRAPID NOVOLET HUMAN ACTRAPID 100 HUMAN INSULATRAD 40 HUMAN MIXTRAD 40 HUMAN MONOTARD 40 MIXTRAD 30 INSUGEN 30/70 INSUGEN 50/50 INSUGEN µN¶ INSUGEN µR¶ LANTUS LANTUS OPTISETS WOSULIN

Company
Eli Lilly Eli Lilly Eli Lilly Eli Lilly Eli Lilly Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Abbott Abbott Abbott Abbott Abbott Abbott Abbott Biocon Biocon Biocon Biocon Sanofi Aventis Sanofi Aventis Wockhard

Avg. Sales/week
35 8 8 3 6 2 4 17 18 3 3 1 1 1 2 2 18 2 5 3 3 2 2 4 3 7

47

Market Share of companies Accrording to Avg. Sale per Week in Pitampura
Sanofi Aventis 4% Wockhard 4%

Biocon 6%

Eli Lilly 37%

Abbott 19%

Novo Nordisk 30%

48

Data Interpretation of South Delhi
Insulin Brand
HUMINSULIN 30/70 HUMINSULIN µN¶ HUMINSULIN µR¶ HUMALOG HUMALOG MIX 50 INJECTION H.INSULIN50/50 ILETIN NOVO MIX ACTRAPID H.INSULATARD HUMAN MIXTRAD 30 HUMAN MIXTRAD 50 NOVA RAPID FLEXPEN NOVOLET PEN ACTRAPID MC ACTRAPID NOVOLET HUMAN ACTRAPID 100 INSULIN ISOPHANE INSULATARD NOVELET HUMAN INSULATRAD 40 HUMAN MIXTRAD 40 HUMAN MONOTARD 40 MIXTRAD 30 INSUGEN 30/70 INSUGEN 50/50 INSUGEN µN¶ INSUGEN µR¶ LANTUS LANTUS OPTISETS INSULIN RAPID WOSULIN

Company
Eli Lilly Eli Lilly Eli Lilly Eli Lilly Eli Lilly Eli Lilly Eli Lilly Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Novo Nordisk Abbott Abbott Abbott Abbott Abbott Abbott Abbott Abbott Abbott Biocon Biocon Biocon Biocon Sanofi Aventis Sanofi Aventis Sanofi Aventis Wockhard

Avg. Sales/week
118 53 51 11 15 4 3 25 23 20 76 72 8 7 4 4 4 14 6 5 10 39 13 4 24 13 13 12 30 7 4

INSULATARD HM PENFIL Novo Nordisk

16
49

Market Share of Companies according to Avg. Sales per week in South Delhi

Wockhard 2% Sanofi Aventis 6% Biocon 9% Eli Lilly 36%

Abbott 14%

Novo Nordisk 33%

50

Findings
During the project work I found that Eli Lilly and Novo nordisk dominate the inslulin market. There are four other companies also in the market but their relative market share is low in comparision of these two companies. Abbott is in third position.These are the list of all Insulin Brand that are available in pitampura and south Delhi Market. 1. HUMINSULIN 30/70 2. HUMINSULIN µN¶ 3. HUMINSULIN µR¶ 4. HUMALOG 5. HUMALOG MIX 50 6. INJECTION HUMINSULIN 50/50 7. ILETIN 8. NOVO MIX 9. ACTRAPID 10. HUMAN INSULATRAD 11. HUMAN MIXTRAD 30 12. HUMAN MIXTRAD 50 13. INSULATARD 14. INSULATARD HM PENFIL 15. NOVA RAPID FLEXPEN 16. NOVOLET PEN 17. ACTRAPID MC 18. ACTRAPID NOVOLET 19. HUMAN ACTRAPID 100 20. HUMAN INSULATRAD 40 21. HUMAN MIXTRAD 40 22. HUMAN MONOTARD 40 23. INSULATRAD 24. INSULATRAD NOVOLET 25. INSULIN ISOPHANE 26. MIXTRAD 30 27. INSUGEN 30/70 28. INSUGEN 50/50 29. INSUGEN µN¶ 30. INSUGEN µR¶ 31. INSULIN RAPID 32. LANTUS 33. LANTUS OPTISETS 34. WOSULIN (ELI LILLY) (ELI LILLY) (ELI LILLY) (ELI LILLY) (ELI LILLY) (ELI LILLY) (ELI LILLY) (NOVO NORDISK) (NOVO NORDISK) (NOVO NORDISK) (NOVO NORDISK) (NOVO NORDISK) (NOVO NORDISK) (NOVO NORDISK) (NOVO NORDISK) (NOVO NORDISK) (ABBOTT) (ABBOTT) (ABBOTT) (ABBOTT) (ABBOTT) (ABBOTT) (ABBOTT) (ABBOTT) (ABBOTT) (ABBOTT) (BIOCON) (BIOCON) (BIOCON) (BIOCON) (SANOFI AVENTIS) (SANOFI AVENTIS) (SANOFI AVENTIS) (WOCKHARD)
51

BIBILIOGRAPHY
Following are certain references made during the course of my project: Primary data gathered through various chemist store and dealers of medicines and other peoples and some other information like profile of Eli Lilly and about insulin are from:

www.lillyindia.co.in www.Google..com www.wikipedia.com Marketing Concept : Marketing Research : News Papers : Philip Kotler G.C. Beri Times of India, Hindustan Times

52